Showing 1 - 3 results of 3 for search 'Pavel Jansa', query time: 0.01s Refine Results
  1. 1
    Long‐Term Treatment With Subcutaneous Treprostinil in Patients With Severe Inoperable Chronic Thromboembolic Pulmonary Hypertension in the Multimodal Therapy Era (Data From CTREPH Study Open Label Extension)

    Long‐Term Treatment With Subcutaneous Treprostinil in Patients With Severe Inoperable Chronic Thromboembolic Pulmonary Hypertension in the Multimodal Therapy Era (Data From CTREPH... by Pavel Jansa, Roela Sadushi‐Kolici, Nika Skoro‐Sajer, Grzegorz Kopec, Iveta Simkova, Regina Steringer‐Mascherbauer, Barbara Salobir, Jaroslav Lindner, Irene M. Lang

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    The incidence of the thrombophilic SNPs rs6025, rs1799963, rs2066865, rs2289252, and rs8176719 in chronic thromboembolic pulmonary hypertension

    The incidence of the thrombophilic SNPs rs6025, rs1799963, rs2066865, rs2289252, and rs8176719 in chronic thromboembolic pulmonary hypertension by Jan Kvasnička MD, PhD, Pavel Jansa MD, PhD, Renata Cífková MD, PhD, Daniela Dušková MD, PhD, Petra Bobčíková MSc, Martin Ševčík MSc, PhD, Zuzana Zenáhlíková MD, PhD, Tomáš Kvasnička MD, PhD

    Published 2024-08-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Relaxin mimetic in pulmonary hypertension associated with left heart disease: Design and rationale of Re‐PHIRE

    Relaxin mimetic in pulmonary hypertension associated with left heart disease: Design and rationale of Re‐PHIRE by Marcin Ufnal, Kathleen Connolly, Marcus Millegard, Elena Surkova, Marco Guazzi, Diana Bonderman, Justin Ezekowitz, Finn Gustafsson, Michał Ciurzyński, Raquel López Vilella, Tariq Ahmad, Roy Gardner, Pavel Jansa, Sandra vanWijk, Koichiro Kinugawa, Erik Björklund, Zhi‐Cheng Jing, Stephan Rosenkranz

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: